Cargando…
Antiangiogenic effects in patients with progressive desmoplastic small round cell tumor: data from the French national registry dedicated to the use of off-labeled targeted therapy in sarcoma (OUTC’s)
BACKGROUND: Desmoplastic small round cell tumor (DSRCT) is a very rare mesenchymal tumor that mainly affects teenagers and young adults with a mean age at diagnosis around 20–25 years. Although initial management still needs standardization, many centers will use multimodal treatment including inten...
Autores principales: | Bétrian, Sarah, Bergeron, Christophe, Blay, Jean-Yves, Bompas, Emmanuelle, Cassier, Philippe A., Chevallier, Laure, Fayette, Jérome, Girodet, Magali, Guillemet, Cécile, Le Cesne, Axel, Marec-Berard, Perrine, Ray-Coquard, Isabelle, Chevreau, Christine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424317/ https://www.ncbi.nlm.nih.gov/pubmed/28491276 http://dx.doi.org/10.1186/s13569-017-0076-4 |
Ejemplares similares
-
The off-label use of targeted therapies in sarcomas: the OUTC’S program
por: Eberst, Lauriane, et al.
Publicado: (2014) -
Desmoplastic Small Round Cell Tumor: Current Management and Recent Findings
por: Dufresne, Armelle, et al.
Publicado: (2012) -
Off-label use of targeted therapies in osteosarcomas: data from the French registry OUTC’S (Observatoire de l’Utilisation des Thérapies Ciblées dans les Sarcomes)
por: Penel-Page, Mathilde, et al.
Publicado: (2015) -
Recombinant erythropoietin for the anaemia of patients with advanced Gastrointestinal Stromal Tumours (GIST) receiving imatinib: an active agent only in non progressive patients
por: Duffaud, Florence, et al.
Publicado: (2012) -
Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in the prospective BFR14 trial
por: Blesius, Aurore, et al.
Publicado: (2011)